These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 23091809)

  • 1. Cyclooxygenase-2 and vascular endothelial growth factor in chronic hepatitis, cirrhosis and hepatocellular carcinoma.
    Kwon SH; Jeong SW; Jang JY; Lee JE; Lee SH; Kim SG; Kim YS; Cho YD; Kim HS; Kim BS; Jin SY
    Clin Mol Hepatol; 2012 Sep; 18(3):287-94. PubMed ID: 23091809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclooxygenase-2 expression in hepatocellular carcinoma, cirrhosis and chronic hepatitis in the United States.
    Pazirandeh S; Khettry U; Gordon FD; Resnick RH; Murray JE; Sheth SG
    Dig Dis Sci; 2007 Jan; 52(1):220-7. PubMed ID: 17160481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cooperative Role of Thrombopoietin and Vascular Endothelial Growth Factor-A in the Progression of Liver Cirrhosis to Hepatocellular Carcinoma.
    Vizio B; Bosco O; David E; Caviglia GP; Abate ML; Schiavello M; Pucci A; Smedile A; Paraluppi G; Romagnoli R; Lupia E; Bellone G; Montrucchio G
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33673041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical assessment of angiogenesis in hepatocellular carcinoma and surrounding cirrhotic liver tissues.
    Deli G; Jin CH; Mu R; Yang S; Liang Y; Chen D; Makuuchi M
    World J Gastroenterol; 2005 Feb; 11(7):960-3. PubMed ID: 15742396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of vascular endothelial growth factor in small hepatocellular carcinoma.
    Iavarone M; Lampertico P; Iannuzzi F; Manenti E; Donato MF; Arosio E; Bertolini F; Primignani M; Sangiovanni A; Colombo M
    J Viral Hepat; 2007 Feb; 14(2):133-9. PubMed ID: 17244253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of P53 and HSP70 in Chronic Hepatitis, Liver Cirrhosis, and Early and Advanced Hepatocellular Carcinoma Tissues and Their Diagnostic Value in Hepatocellular Carcinoma: An Immunohistochemical Study.
    Wang Z; Gou W; Liu M; Sang W; Chu H; Zhang W
    Med Sci Monit; 2015 Oct; 21():3209-15. PubMed ID: 26494212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical angiogenic biomarkers in hepatocellular carcinoma and cirrhosis: correlation with pathological features.
    Ribeiro OD; Canedo NH; Pannain VL
    Clinics (Sao Paulo); 2016 Nov; 71(11):639-643. PubMed ID: 27982164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of cyclooxygenase-2 and transforming growth factor-beta1 in HCV-induced chronic liver disease and hepatocellular carcinoma.
    El-Bassiouny AE; Zoheiry MM; Nosseir MM; El-Ahwany EG; Ibrahim RA; El-Bassiouni NE
    MedGenMed; 2007 Aug; 9(3):45. PubMed ID: 18092051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating vascular endothelial growth factor (VEGF) is a possible tumor marker for metastasis in human hepatocellular carcinoma.
    Jinno K; Tanimizu M; Hyodo I; Nishikawa Y; Hosokawa Y; Doi T; Endo H; Yamashita T; Okada Y
    J Gastroenterol; 1998 Jun; 33(3):376-82. PubMed ID: 9658317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor-alpha and epidermal growth factor receptor in chronic liver disease and hepatocellular carcinoma.
    Harada K; Shiota G; Kawasaki H
    Liver; 1999 Aug; 19(4):318-25. PubMed ID: 10459631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The Expressions of Somatostatin and Cycloxygenase-2 in Chronic Hepatitis, Hepatic Cirrhosis, Precancerous Lesion and Hepatocellular Carcinoma].
    Xie YM; Li X; Yan LN; Wei B; Wang CH; Tang CW
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 Sep; 46(5):710-6. PubMed ID: 26619541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor cyclooxygenase-2 levels correlate with tumor invasiveness in human hepatocellular carcinoma.
    Tang TC; Poon RT; Lau CP; Xie D; Fan ST
    World J Gastroenterol; 2005 Apr; 11(13):1896-902. PubMed ID: 15800977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expressions of inducible nitric oxide synthase and vascular endothelial growth factor and their relationship with microvessel density in hepatocellular carcinoma].
    Xiao G; Zhang WM; Zhang M; Xie D; Guo AL; Wen JM
    Ai Zheng; 2005 Jan; 24(1):99-103. PubMed ID: 15642211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor in hepatocellular carcinoma: Impact on neovascularization and survival.
    Huang GW; Yang LY; Lu WQ
    World J Gastroenterol; 2005 Mar; 11(11):1705-8. PubMed ID: 15786555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of PTEN, Cx43, and VEGF in hepatocellular carcinoma].
    Zhang TY; An JL; Gu JY; He S
    Ai Zheng; 2004 Jun; 23(6):662-6. PubMed ID: 15191666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular density and VEGF expression in hepatic lesions.
    Brodsky SV; Mendelev N; Melamed M; Ramaswamy G
    J Gastrointestin Liver Dis; 2007 Dec; 16(4):373-7. PubMed ID: 18193117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression and clinical impact of vascular endothelial growth factor and matrix metalloproteinase-2 in hepatocellular carcinoma].
    Guo RP; Zhong C; Shi M; Zhang CQ; Wei W; Zhang YQ; Li JQ
    Zhonghua Zhong Liu Za Zhi; 2006 Apr; 28(4):285-8. PubMed ID: 16875630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclooxygenase-2 pathway correlates with vascular endothelial growth factor expression and tumor angiogenesis in hepatitis B virus-associated hepatocellular carcinoma.
    Cheng AS; Chan HL; To KF; Leung WK; Chan KK; Liew CT; Sung JJ
    Int J Oncol; 2004 Apr; 24(4):853-60. PubMed ID: 15010822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-mobility group protein box1 expression correlates with peritumoral macrophage infiltration and unfavorable prognosis in patients with hepatocellular carcinoma and cirrhosis.
    Zhang QB; Jia QA; Wang H; Hu CX; Sun D; Jiang RD; Zhang ZL
    BMC Cancer; 2016 Nov; 16(1):880. PubMed ID: 27836008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of microRNA-16, microRNA-21 and microRNA-101 expression with cyclooxygenase-2 expression and angiogenic factors in cirrhotic and noncirrhotic human hepatocellular carcinoma.
    Zeng W; van den Berg A; Huitema S; Gouw AS; Molema G; de Jong KP
    PLoS One; 2014; 9(4):e95826. PubMed ID: 24759835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.